ADVERTORIAL
It ’ s all about care …
BIOVECTRA launched a new logo and brand to align with the company ’ s core values and full suite of expertise in complex chemistry , biologics , and bioreagents
BIOVECTRA , Inc . is a forwardthinking CDMO , with full-service , clinical-to-commercial scale GMP outsourcing solutions for critical raw materials , intermediates , APIs and biologic drug substances . It operates five cGMP facilities in Eastern Canada and continues to invest in additional technologies and expansions to meet the growing requirements of its client base .
Driven by the launch of its new website ( biovectra . com ) BIOVECTRA ’ s new brand is built on three pillars of care : patients ’ needs , progressive manufacturing science and a highly skilled and dedicated team . “ Together with our partners , solving complex manufacturing problems in small molecules and biologics to meet the needs of patients is our mission ,” says CEO Oliver Technow . “ Caring deeply about client programs is , and always has been , our nature .”
For over 50 years , BIOVECTRA ’ s APIs have been used to treat cancer , kidney disease , cardiovascular disease , multiple sclerosis and many others . The addition of biologics capabilities has amplified the company ’ s ability to help by entering a field where therapies are advancing rapidly and changing the way healthcare is delivered .
In addition , BIOVECTRA has bolstered its capacity and enhanced its range of scales through the recent completion of expansion projects at two sites . “ In Charlottetown , Prince Edward Island , we have added over 60,000 square feet to our API footprint , invested in multireactor systems for higher throughputs and fortified our large-scale synthetic chemistry and analytical development capabilities ,” says CCO Heather Delage .
“ Similarly , in Windsor , Nova Scotia , our expansion projects have focused on increasing capacity for biologics development , clinical manufacturing and commercial manufacturing up to 17,000 L bioreactor capacity .”
BIOVECTRA also intends to add another single-use clinical-scale suite ( 100- 1,000L ) at Windsor , slated to be available in early 2022 .
The dedicated team of 500 + highly skilled professionals approach every project like it is their own . From responsive and open project management to experienced process development and engineering , they infuse authentic care into everything they do . “ When we say team , we truly include our global partners ,” Delage says . “ We want our partners to feel like they are part of BIOVECTRA , and us part of their journey towards improving the lives of patients .”
While the increased demands COVID-19 has placed on biologics manufacturing capacity are significant and accelerated , BIOVECTRA has been on a trajectory of building diversified offerings over the past decade . As such , it is one of the few commercially proven CDMOs able to support clients ’ most complex outsourcing and supply chain requirements .
Dr Marc Sauer , VP and GM of Process Science & Development Services , oversees 65 scientists who are an integral part of BIOVECTRA ’ s project teams . The depth and diversity of experience ( collectively , the company has handled over 800 development programs
to date ) is applied in a rigorous standard approach that includes :
• Thorough analysis of project suitability
• Quality by Design methodology
• Coordinated expertise in phaseappropriate quality project support
• Successful management of validation to commercialization
• Confident technical teams that improve program outcomes BIOVECTRA has also undertaken many customized capacity expansions in partnership with its clients . ‘ I am always amazed by the expertise of our process engineering team and their commitment to on-time project delivery . They work under tight timelines to configure the facilities and design equipment optimally , all while the process development work is still in progress ,” notes Dr Sauer .
BIOVECTRA is looking forward to its next 50 years of serving its partners and the patients they serve . It really is a very simple , but long-standing value that its leadership believes will continue to underpin the development and manufacture the most complex small molecules and biologics . ‘ It ’ s all about care .’ •
JUL / AUG 2021 SPECCHEMONLINE . COM 57